NYSE · BFLY
Healthcare · Medical - Devices
$6.51
Up+$0.57 (+8.76%)
Updated Nov 11, 2026, 8:32 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BFLY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 10, 2026
BFLY closed at $6.51 after 21 trading sessions, down 19.63% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | $6.53 | $6.8199 | $6.38 | $6.51 | 4.28M |
| Nov 9, 2026 | $6.42 | $6.76 | $6.30 | $6.67 | 3.81M |
| Nov 6, 2026 | $6.15 | $6.425 | $6.07 | $6.37 | 3.48M |
| Nov 5, 2026 | $6.67 | $6.70 | $5.855 | $6.07 | 6.67M |
| Nov 4, 2026 | $6.50 | $6.92 | $6.50 | $6.77 | 5.89M |
| Nov 3, 2026 | $6.30 | $6.4594 | $6.22 | $6.40 | 4.05M |
| Nov 2, 2026 | $6.51 | $6.5399 | $6.09 | $6.14 | 5.25M |
| Oct 30, 2026 | $7.18 | $7.18 | $6.29 | $6.39 | 7.48M |
| Oct 29, 2026 | $7.045 | $7.93 | $6.93 | $7.51 | 5.9M |
| Oct 28, 2026 | $7.42 | $7.875 | $7.39 | $7.81 | 5.6M |
| Oct 27, 2026 | $6.76 | $7.41 | $6.6889 | $7.38 | 4.92M |
| Oct 26, 2026 | $6.75 | $6.84 | $6.58 | $6.66 | 3.51M |
| Oct 23, 2026 | $6.85 | $6.93 | $6.58 | $6.76 | 4.2M |
| Oct 22, 2026 | $6.95 | $7.165 | $6.60 | $6.81 | 5.5M |
| Oct 21, 2026 | $7.35 | $7.445 | $7.08 | $7.10 | 4.97M |
| Oct 20, 2026 | $7.46 | $7.55 | $7.265 | $7.31 | 3.48M |
| Oct 19, 2026 | $7.50 | $7.60 | $7.37 | $7.47 | 2.87M |
| Oct 16, 2026 | $7.80 | $7.902 | $7.22 | $7.25 | 4.57M |
| Oct 15, 2026 | $7.50 | $7.925 | $7.26 | $7.85 | 4.1M |
| Oct 14, 2026 | $7.87 | $8.10 | $7.5125 | $7.60 | 4.13M |
| Oct 13, 2026 | $8.50 | $8.51 | $8.01 | $8.10 | 4.66M |
The latest Smart Investors Daily articles mentioning BFLY.
Company
Market Activity
Research & News
BFLY research
Company profile and research snapshot.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2026 | Canaccord Genuity | Buy | — |
| Sep 29, 2026 | Evercore ISI Group | Outperform | — |
| Sep 22, 2026 | Needham | Buy | — |
| Sep 11, 2026 | TD Cowen | Buy | — |
| Feb 27, 2026 | TD Cowen | Buy | — |
Generated Nov 11, 2026, 5:01 PM
Butterfly Network shares gained nearly 6% today following the company's presentation at the 2026 UBS Global Healthcare Conference, signaling renewed investor interest in the ultrasound technology innovator. While the conference presentation itself carries neutral sentiment, the market's positive reaction suggests investors are responding favorably to management's strategic messaging and market positioning.
Bottom line: BFLY's 6% daily gain reflects positive investor sentiment around the company's UBS Conference presentation, though the neutral conference sentiment suggests the rally may be more about visibility and sector momentum than specific catalysts. Investors should review the full presentation transcript to assess whether management disclosed meaningful developments that justify the move, and monitor upcoming quarterly earnings for evidence of sustainable commercial traction.
SeekingAlpha · Nov 10, 2026
Butterfly Network, Inc. (BFLY) 2026 UBS Global Healthcare Conference November 10, 2026 8:45 AM ESTCompany ParticipantsJoseph DeVivo - CEO, President &...
Yahoo · Nov 6, 2026
Reduce costs and infection risks with non-invasive, AI-enabled portable scanners while targeting home care, telemedicine and aging-population demandDublin, Nov. 06, 2026 (GLOBE NEWSWIRE) -- "Bladder Scanners - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global bladder scanners market was valued at US$131.2 million in 2025 and is projected to reach US$179.1 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.5%. Market growth is s
Yahoo · Oct 31, 2026
Butterfly Network just watched its stock drop 14.9% to US$6.39 in Friday trading, even as the latest Q3 2026 report landed with one of the cleanest stories this medtech has put up in a while. Revenue reached US$32.6m and adjusted gross margin hit 73%, both key markers for any medical equipment player trying to scale. The short-term reaction is all about a volatile chart. The longer view now centers on whether this pace of high-margin, software and embedded ultrasound contracts can sustain a...
Yahoo · Oct 30, 2026
Butterfly Network (NYSE:BFLY) reported third-quarter 2026 revenue of $32.6 million, up 52% from a year earlier and 9% above the high end of its guidance range, as growth in its Embedded business and enterprise-focused point-of-care ultrasound operations lifted results. The company also posted its h
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BFLY.
